Question follow-through · 81941

Respiratory Syncytial Virus: Vaccination

To ask the Secretary of State for Health and Social Care, what steps he is taking to gather additional data on the (a) effectiveness and (b) safety of the Respiratory Syncytial Virus vaccination in people that are over 80.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
14 Oct 2025
Target answer date
16 Oct 2025
Answer
4 Nov 2025 · 21 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 14 Oct 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, what steps he is taking to gather additional data on the (a) effectiveness and (b) safety of the Respiratory Syncytial Virus vaccination in people that are over 80.

  2. 16 Oct 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 4 Nov 2025

    Answer published

    The UK Health Security Agency (UKHSA) undertakes monitoring and evaluation of immunisation programmes, including the effectiveness of vaccines. The Medicines and Healthcare Products Regulatory Agency (MHRA) monitors vaccine safety. The UKHSA and the MHRA ...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Heart Diseases: Young People

3 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help raise awareness among young people of the risks of sudden cardiac death in (a) grassroots sports clubs and (b) higher education settings.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Heart Diseases: Young People

3 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to introduce screening for asymptomatic heart conditions in young people in sports settings.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Professions: Regulation

10 Dec 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made on the potential merits of statutory regulation of therapy titles.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Mesothelioma: Medical Treatments

2 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will consider establishing a national clinical audit for people living with mesothelioma to understand a) the need for preventative measures and b) the scale of treatment needed.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Mesothelioma: Nurses

2 Jan 2026 · To ask the Secretary of State for Health and Social Care, if he will consider specific funding for mesothelioma nursing posts.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Depressive Illnesses: Ketamine

9 Jan 2026 · To ask the Secretary of State for Health and Social Care, whether he plans to request that NICE conduct an exceptional (expedited) partial review of the NICE Depression guideline (NG222) to consider the inclusion of intravenous racemic ketamine as an opti

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Epilepsy: Research

26 Jan 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of increasing funding for epilepsy research.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Lipoedema

9 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether lipoedema has a diagnostic code within NHS data systems; what steps he is taking to improve the collection of data on prevalence, diagnosis and outcomes for people with lipoedema; and what

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Lipoedema

9 Feb 2026 · To ask the Secretary of State for Health and Social Care, what training and guidance is provided to GPs and other frontline clinicians on recognising and managing lipoedema; and whether he plans to review undergraduate, postgraduate and continuing profess

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Lipoedema

9 Feb 2026 · To ask the Secretary of State for Health and Social Care, how lipoedema is classified within NICE guidance and NHS commissioning frameworks; and whether he plans to review the categorisation of lipoedema-related interventions to ensure they reflect clinic

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Prescription Drugs: Cost Effectiveness

20 Feb 2026 · To ask the Secretary of State for Health and Social Care, when his Department plans to release an impact assessment for changes to the NICE cost-effectiveness threshold.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Finance

3 Mar 2026 · To ask the Secretary of State for Health and Social Care, with reference to the Answer of 1 May 2024 to Question 19413 on NHS: Expenditure, how much NHS England, clinical commissioning groups and integrated care boards spent in aggregate on (a) mental hea